Deep TMS for PTSD With Suicidal Ideation
Key facts
- Who runs it
- D.R. Rut Zaks OHAYON
- Where
- Israel1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 72 people, planned
- Started
- Oct 2026
- Expected to end
- Oct 2029
- Type of study
- Interventional
- Treatments tested
- Deep Transcranial Magnetic Stimulation (DTMS)
- Record updated
- 19 October 2026
Who can take part
- Age
- 22 years to 68 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (18)Hide the full registry criteria
Who can take part
- Adults 22-68 years old
- Male or female
- Diagnosis of PTSD according to DSM-5 criteria
- Active suicidal ideation at screening, confirmed by the Beck Scale for Suicide Ideation (SSI)
- Able to provide informed consent
- Stable psychiatric medication regimen for at least 4 weeks prior to enrollment (if applicable)
- Able to comply with study procedures and attend scheduled sessions
Who cannot take part
- Prior non-response to adequate TMS treatment
- Current psychotic disorder, bipolar disorder, or severe personality disorder
- Substance use disorder within the past 3 months (excluding nicotine or caffeine)
- Significant neurological disorder or history of seizures
- Contraindications to TMS (e.g., metallic implants in the head, implanted medical devices, history of epilepsy)
- Current use of medications that significantly lower seizure threshold
- Acute medical illness or unstable medical condition
- Cognitive impairment that would interfere with participation (based on MoCA)
- Pregnancy or breastfeeding
- Imminent risk requiring a higher level of care (e.g., hospitalization)
- Participation in another interventional study within the past 30 days
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Post traumatic stress disorder PTSD or suicidal ideation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether deep transcranial magnetic stimulation (DTMS) using the H1-coil can safely and effectively reduce suicidal ideation in adults diagnosed with post-traumatic stress disorder (PTSD). The main questions it aims to answer are: (1) Does DTMS reduce suicidal ideation in adults with PTSD? (2) Does DTMS improve PTSD symptoms?. DTMS is administered together with a brief exposure procedure intended to activate trauma-related neural circuits before stimulation.
The group in the trial
- DTMS with ExposureTreatment being tested
High-frequency Deep TMS using the H1-coil, with each session preceded by a brief script-driven exposure procedure.
Treatment: Deep Transcranial Magnetic Stimulation (DTMS)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective Study to Evaluate the Safety and Efficacy of Deep Transcranial Magnetic Stimulation (DTMS) for the Treatment of PTSD-Associated Suicidal Ideation (PTSD-SI)
- Criteria questions
- Built from NCT07880340, who can take part
- Record updated
- 19 October 2026